| 5-Day | 34,813 |
| 10-Day | 30,718 |
| 30-Day | 31,729 |
| 5-Day | 34,813 |
| 10-Day | 30,718 |
| 30-Day | 31,729 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 130 | 1587.20 | 1590.35 | 1 |
| 227 | 1587.00 | 1590.40 | 1 |
| 20 | 1584.10 | 1590.50 | 100 |
| 200 | 1581.20 | 1590.60 | 58 |
| 7 | 1580.00 | 1594.00 | 1 |
| 1258 | Total | 821 | Total |
Buy Qty
1258
Sell QTY
821
| 5-Day | 951,165 |
| 10-Day | 938,342 |
| 30-Day | 719,869 |
| 5-Day | 951,165 |
| 10-Day | 938,342 |
| 30-Day | 719,869 |
Divis Labs
Sentimeter
62% of moneycontrol users recommend buying Divis Labs.
What's your call on Divis Labs today?
Read 11 investor views
Top Trading Ideas
15 February 2019
sell TitanCompany Feb Fut |
Entry Price (Rs) 1,043.55 |
Exit Price (Rs) 1,028.00 |
Gain (Rs) 16.00 |
sell UnitedBrewerie Feb Fut |
Entry Price (Rs) 1,401.45 |
Exit Price (Rs) 1,346.00 |
Gain (Rs) 55.00 |
| Days | BSE | NSE |
| 30 | 1550.87 | 1551.24 |
| 50 | 1522.84 | 1523.36 |
| 150 | 1379.88 | 1380.42 |
| 200 | 1309.64 | 1310.25 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Divis Labs
| Standalone | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
| Net Sales | 1,342.92 | 1,285.00 | 995.31 | 1,087.95 |
| Other Income | 34.56 | 80.05 | 48.79 | 48.17 |
| PBDIT | 523.33 | 514.13 | 351.86 | 386.50 |
| Net Profit | 379.49 | 397.65 | 266.16 | 261.60 |
| Total Share Capital | 53.09 |
| Net Worth | 5,959.65 |
| Total Debt | 63.11 |
| Net Block | 1,995.88 |
| Investments | 1,896.66 |
| Total Assets | 6,022.76 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 414.35 | -0.18 | 678.80 | 375.40 | 99,416.44 |
| Cipla | 539.20 | -0.40 | 678.00 | 483.75 | 43,443.05 |
| Divis Labs | 1588.50 | 0.88 | 1697.65 | 981.05 | 42,169.68 |
| Dr Reddys Labs | 2532.70 | -1.28 | 2875.00 | 1888.00 | 42,058.23 |
| Aurobindo Pharm | 708.95 | -1.27 | 830.00 | 527.05 | 41,537.92 |
| More » | |||||
| Dec' 18 | Sep' 18 | Jun' 18 | Mar' 18 | |
| Promoter | 52.01 | 52.02 | 52.03 | 52.05 |
| Public (FII + DII) | 47.99 | 47.98 | 47.97 | 47.95 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| SBI Equity Hybrid Fund (G) | 4,314,655 |
| Reliance Multi Cap Fund - Retail Plan (G) | 2,431,762 |
| SBI Blue Chip Fund (G) | 2,051,484 |
| Reliance Large Cap Fund - Retail Plan (G) | 1,957,638 |
WPIL Recommended on Apr 26th 2017
Recommended price 458.00 | Peak from reco 987.00 115.53%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Divis Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 42,169.68 crore.
The company management includes Murali K Divi - Chairman & Managing Director, Madhusudana Rao Divi - Whole Time Director, Kiran S Divi - Whole Time Director, Nilima Motaparti - Whole Time Director, N V Ramana - Executive Director, K V K Seshavataram - Independent Director, G Suresh Kumar - Independent Director, R Ranga Rao - Independent Director, Ramesh B V Nimmagadda - Independent Director, S Ganapaty - Independent Director.
It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB.
Its Registered office is at Divi Towers, 1-72/23(P)/DIVIS/303,,Cyber Hills, Gachibowli, Hyderabad,Telangana - 500032.
Their Registrars are Karvy Computershare Private Ltd.
SET SMS ALERT
